ifosfamide has been researched along with Genetic Predisposition in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " The male patient was enrolled into the research programme for the evaluation of the association between deletion of the genes encoding a number of classes of glutathione S-transferases (GST) and adverse reactions to alkylating agents." | 5.31 | Growth retardation and osteomalacia as a result of ifosfamide nephrotoxicity in a 3-year-old boy whose genotype reveals the genes encoding glutathione S-transferases GSTM1 and GSTT1. ( Bodalski, J; Zielińska, E, 2001) |
| "Ifosfamide (IFA) is a potent alkylating antitumoral agent, but its use is limited by neurological side effects." | 1.48 | Possible role of CYP2B6 genetic polymorphisms in ifosfamide-induced encephalopathy: report of three cases. ( Bellien, J; Duflot, T; Filhon, B; Joannidès, R; Lamoureux, F; Marie-Cardine, A; Massy-Guillemant, N; Pereira, T; Verstuyft, C, 2018) |
| " The male patient was enrolled into the research programme for the evaluation of the association between deletion of the genes encoding a number of classes of glutathione S-transferases (GST) and adverse reactions to alkylating agents." | 1.31 | Growth retardation and osteomalacia as a result of ifosfamide nephrotoxicity in a 3-year-old boy whose genotype reveals the genes encoding glutathione S-transferases GSTM1 and GSTT1. ( Bodalski, J; Zielińska, E, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duflot, T | 1 |
| Marie-Cardine, A | 1 |
| Verstuyft, C | 1 |
| Filhon, B | 1 |
| Pereira, T | 1 |
| Massy-Guillemant, N | 1 |
| Joannidès, R | 1 |
| Bellien, J | 1 |
| Lamoureux, F | 1 |
| Zielińska, E | 1 |
| Bodalski, J | 1 |
2 other studies available for ifosfamide and Genetic Predisposition
| Article | Year |
|---|---|
Possible role of CYP2B6 genetic polymorphisms in ifosfamide-induced encephalopathy: report of three cases.
Topics: Administration, Intravenous; Adolescent; Antineoplastic Agents, Alkylating; Bone Neoplasms; Brain Di | 2018 |
Growth retardation and osteomalacia as a result of ifosfamide nephrotoxicity in a 3-year-old boy whose genotype reveals the genes encoding glutathione S-transferases GSTM1 and GSTT1.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; | 2001 |